Epidemiology, Identification Rate and Treatment Penetration of Osteoporotic Vertebral Fractures in Switzerland
NCT ID: NCT02234414
Last Updated: 2014-09-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
303 participants
OBSERVATIONAL
2009-02-28
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Clinical signs and symptoms leading to the suspicion of vertebral fracture(s) lack either sensitivity (wall-occiput distance) or specificity (rib-pelvis distance). Whether a combination of both would improve sensitivity and specificity is unknown.
The gold standard for the diagnosis of vertebral fracture relies on antero-posterior and lateral X-Rays of the thoracic and lumbar spine. Despite standardization of X-Ray readings, a retrospective study of hospitalized elderly patients has shown that as many as 50% of the radiographic reports failed to note the presence of moderate to severe vertebral fractures. In a primary care setting, fewer than 2% of the women received diagnoses of osteoporosis or vertebral fracture, although expected prevalence is 20% to 30% and appropriate drug treatment was offered to only 36% of the diagnosed patients.
The recent availability of software for vertebral fracture assessment (VFA) coupled to DXA measurements allows for the detection of vertebral deformities, which is critical for management of osteoporosis, as the existence of such deformities substantially increases the risk of subsequent fracture. Recently published results show that VFA allows the diagnosis of a vertebral fracture. The sensitivity of VFA for detection of vertebral fractures compared to expert radiologist reading of X-ray is excellent for grade 2 and 3 fractures, ranging between 90-94%.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality of the Detection & Treatment of Osteoporotic Fractures in a Swiss Trauma Center
NCT02157753
Impact of Osteoporotic Fractures on Work: Data From a Fracture Liaisons Service
NCT04781556
Addressing Vertebral Osteoporosis Incidentally Detected to Prevent Future Fractures
NCT00388908
The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures
NCT07027306
Evaluation of the Impact of a Case-finding Strategy for Vertebral Fractures
NCT00463905
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Community-dwelling women from a random sample (address lists may be chosen from public and/ or private providers)
* Aged 65-79 yrs
* Written informed consent
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 65-79 yrs
* Written informed consent
Exclusion Criteria
* Not willing or not able to sign informed consent
* In patients not willing or not able to participate, the reason for denial will be recorded for future evaluation.
65 Years
79 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prof. Dr. med. Kurt Lippuner
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. med. Kurt Lippuner
President
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kurt Lippuner, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Interessengemeinschaft Osteoporose
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kantonsspital Olten
Olten, , Switzerland
HFR Tafers
Tafers, , Switzerland
Hochgebirgsklinik Davos
Wolfgang, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IGO-SwOF 01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.